Forte Biosciences (FBRX) Amortizatization of Intangibles (2016 - 2026)
Forte Biosciences (FBRX) reported Amortizatization of Intangibles of $7000.0 for Q1 2026, down 97.08% year-over-year from $240000.0 in Q1 2025, and up 177.78% quarter-over-quarter from -$9000.0 in Q4 2025.
Forte Biosciences (FBRX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 8 years of Amortizatization of Intangibles data on file, last reported at $7000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $7000.0, down 97.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $4000.0 (down 98.98% YoY), and the FY2025 annual result was $237000.0, up 50.0% from the prior year.
- Amortizatization of Intangibles rose to $7000.0 in Q1 2026 per FBRX's latest filing, from -$9000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $240000.0 in Q1 2025 and troughed at -$9000.0 in Q3 2024.
- A 3-year average of $50250.0 and a median of $6000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 3900.0% in 2025 and fell as far as 105.77% in 2025.
- A 3-year view of Amortizatization of Intangibles shows it stood at $156000.0 in 2024, then plunged by 105.77% to -$9000.0 in 2025, then soared by 177.78% to $7000.0 in 2026.
- Business Quant data shows FBRX's Amortizatization of Intangibles at $7000.0 in Q1 2026, -$9000.0 in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2020 | -103,000.00 |
| Mar 31, 2020 | -103,000.00 |
| Dec 31, 2019 | -59,000.00 |
| Dec 31, 2019 | -59,000.00 |